Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1492-1496

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solini, A.
Right arrow Articles by Fellin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solini, A.
Right arrow Articles by Fellin, R.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Energy metabolism
Right arrow Hypertension - basic studies
Right arrow Type 2 diabetes

(Hypertension. 2001;37:1492.)
© 2001 American Heart Association, Inc.


Scientific Contributions

A Defect in Glycogen Synthesis Characterizes Insulin Resistance in Hypertensive Patients With Type 2 Diabetes

Anna Solini; Francesco Di Virgilio; Paola Chiozzi; Paola Fioretto; Angela Passaro; Renato Fellin

From the Department of Clinical and Experimental Medicine (A.S., A.P., R.F.) and Section of General Pathology (F.D.V., P.C.), University of Ferrara, Ferrara, Italy; and Department of Internal Medicine (P.F.), University of Padova, Padova, Italy.

Correspondence to Anna Solini, MD, PhD, Department of Clinical and Experimental Medicine, Section of Internal Medicine II, Via Savonarola, 9, I-44100 Ferrara, Italy. E-mail sli{at}dns.unife.it

Abstract—A subgroup of patients with type 2 diabetes shows a clustering of abnormalities such as peripheral insulin resistance, hypertension, and microalbuminuria. To evaluate whether these traits reflect intrinsic disorders of cell function rather than in vivo environmental effects, we studied a group of 7 nondiabetic hypertensive subjects with an altered albumin excretion rate (AER) (HyMA+) and 3 groups of patients with type 2 diabetes: 7 with normal blood pressure and normal AER (DH-MA-), 7 with high blood pressure and normal AER (DH+MA-), and 7 with both high blood pressure and altered AER (DH+MA+). Glucose disposal was measured during an hyperinsulinemic clamp (40 mU · m2-1 · min-1) with primed deuterated [6.6 2H2] glucose infusion. In the same subjects, a skin biopsy was performed and the following parameters were investigated: glucose transport (as determined by [3H]2-deoxyglucose uptake); glycogen synthase activity (as determined by [14C] glucose incorporation from UDP-[U-14C] glucose into glycogen); glycogen phosphorylase activity (as measured by the incorporation of [U-14C]glucose 1-phosphate into glycogen); and total glycogen content. In vivo glucose disposal was significantly reduced in DH+MA- and DH+MA+, with respect to DH-MA-, HyMA+, and controls. Insulin-stimulated glucose transport was similar in the 3 groups of patients with diabetes. A significant reduction of intracellular glycogen content was observed in DH+MA- and DH+MA+ compared with DH-MA- in both basal and insulin-stimulated conditions, probably because of a major impairment of glycogen synthase activity. Glycogen phosphorylase activity did not show differences between the groups. These results suggest that (1) the combination of type 2 diabetes with hypertension and altered AER is associated with impaired insulin sensitivity, and (2) intrinsic, possibly genetic, factors may account for increased peripheral insulin resistance in hypertensive microalbuminuric patients with type 2 diabetes, pointing to the reduction of glycogen synthase activity as a shared common defect.


Key Words: blood pressure • diabetes • insulin resistance • glycogen synthase • fibroblasts




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Knauf, P. D. Cani, A. Ait-Belgnaoui, A. Benani, C. Dray, C. Cabou, A. Colom, M. Uldry, S. Rastrelli, E. Sabatier, et al.
Brain Glucagon-Like Peptide 1 Signaling Controls the Onset of High-Fat Diet-Induced Insulin Resistance and Reduces Energy Expenditure
Endocrinology, October 1, 2008; 149(10): 4768 - 4777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Valverde, M. Lindell, E. G. H. Wagner, and D. Haas
A Repeated GGA Motif Is Critical for the Activity and Stability of the Riboregulator RsmY of Pseudomonas fluorescens
J. Biol. Chem., June 11, 2004; 279(24): 25066 - 25074.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Rheaume, P.-H. Waib, N'G. Kouame, A. Nadeau, Y. Lacourciere, D. R. Joanisse, J.-A. Simoneau, and J. Cleroux
Effects of Intense and Prolonged Exercise on Insulin Sensitivity and Glycogen Metabolism in Hypertensive Subjects
Circulation, November 25, 2003; 108(21): 2653 - 2659.
[Abstract] [Full Text] [PDF]